9 February 2021
Health for Life Capital II™ fund, managed by Seventure Partners, makes two new immuno-oncology (I/O) investments
Seventure led $10M round for new French company focusing on I/O-microbiome and provided $3M seed funding to ErVaccine, driving an increased I/O microbiome focus in fund...